Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-2094

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage ; volume:14 ; number:1 ; day:4 ; month:8 ; year:2017 ; pages:1 ; date:12.2017
Journal of neuroinflammation ; 14, Heft 1 (4.8.2017), 1, 12.2017

Keyword: Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie

Creator: Abad, Catalina

Contributor: Jayaram, Bhavaani
Becquet, Laurine
Wang, Yuqi
O’Dorisio, M. Sue
Waschek, James A.
Tan, Yossan-Var
SpringerLink (Online service)

DOI: 10.1186/s12974-017-0927-1

URN: urn:nbn:de:1111-2017102010648

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Abad, Catalina
Jayaram, Bhavaani
Becquet, Laurine
Wang, Yuqi
O’Dorisio, M. Sue
Waschek, James A.
Tan, Yossan-Var
SpringerLink (Online service)

Other Objects (12)

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs

Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection

Ginsenoside ameliorated ventilator-induced lung injury in rats

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Hochschulschrift

Über postvaccinale Encephalomyelitis

Encephalomyelitis by adenovirus

Kapitel

Exhibit 183

Akten

Exhibit 25

Kapitel

Exhibit 198

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs

Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection

Ginsenoside ameliorated ventilator-induced lung injury in rats

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Hochschulschrift

Über postvaccinale Encephalomyelitis

Encephalomyelitis by adenovirus

Kapitel

Exhibit 183

Akten

Exhibit 25

Kapitel

Exhibit 198

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs

Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection

Ginsenoside ameliorated ventilator-induced lung injury in rats

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Hochschulschrift

Über postvaccinale Encephalomyelitis

Encephalomyelitis by adenovirus

Kapitel

Exhibit 183

Akten

Exhibit 25

Kapitel

Exhibit 198

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs

Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection

Ginsenoside ameliorated ventilator-induced lung injury in rats

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Über postvaccinale Encephalomyelitis

Encephalomyelitis by adenovirus

Exhibit 183

Exhibit 25

Exhibit 198

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs

Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection

Ginsenoside ameliorated ventilator-induced lung injury in rats

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Über postvaccinale Encephalomyelitis

Encephalomyelitis by adenovirus

Exhibit 183

Exhibit 25

Exhibit 198

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs

Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection

Ginsenoside ameliorated ventilator-induced lung injury in rats

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Über postvaccinale Encephalomyelitis

Encephalomyelitis by adenovirus

Exhibit 183

Exhibit 25

Exhibit 198

Related objects

Reset password